Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Jordan R. Warford, Anna Claire Lamport, Derek R. Clements, Alicia Malone, Barry E. Kennedy, Youra Kim, Shashi A. Gujar, David W. Hoskin, Alexander S. Easton

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)
Original languageEnglish
Pages (from-to)4
Number of pages1
JournalActa neuropathologica communications
Volume6
Issue number1
DOIs
Publication statusPublished - Jan 4 2018
Externally publishedYes

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Pathology and Forensic Medicine

Keywords

  • Experimental autoimmune encephalomyelitis
  • Lysolecithin
  • Multiple sclerosis
  • Proteoglycan
  • Surfen

Fingerprint

Dive into the research topics of 'Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis'. Together they form a unique fingerprint.

Cite this

Warford, J. R., Lamport, A. C., Clements, D. R., Malone, A., Kennedy, B. E., Kim, Y., Gujar, S. A., Hoskin, D. W., & Easton, A. S. (2018). Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis. Acta neuropathologica communications, 6(1), 4. https://doi.org/10.1186/s40478-017-0506-9